Product Details for ANDA 200834
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE)
EQ 37.5MG BASE
Marketing Status: Prescription
EQ 75MG BASE
Marketing Status: Prescription
EQ 150MG BASE
Marketing Status: Prescription
EQ 37.5MG BASE
Marketing Status: Prescription
Active Ingredient: VENLAFAXINE HYDROCHLORIDE
Proprietary Name: VENLAFAXINE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: EQ 37.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A200834
Product Number: 001
Approval Date: Apr 14, 2011
Applicant Holder Full Name: AUROBINDO PHARMA LIMITED
Marketing Status: Prescription
Patent and Exclusivity Information
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE)
Proprietary Name: VENLAFAXINE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: EQ 37.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A200834
Product Number: 001
Approval Date: Apr 14, 2011
Applicant Holder Full Name: AUROBINDO PHARMA LIMITED
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 75MG BASE
Marketing Status: Prescription
Active Ingredient: VENLAFAXINE HYDROCHLORIDE
Proprietary Name: VENLAFAXINE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: EQ 75MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A200834
Product Number: 002
Approval Date: Apr 14, 2011
Applicant Holder Full Name: AUROBINDO PHARMA LIMITED
Marketing Status: Prescription
Patent and Exclusivity Information
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE)
Proprietary Name: VENLAFAXINE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: EQ 75MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A200834
Product Number: 002
Approval Date: Apr 14, 2011
Applicant Holder Full Name: AUROBINDO PHARMA LIMITED
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 150MG BASE
Marketing Status: Prescription
Active Ingredient: VENLAFAXINE HYDROCHLORIDE
Proprietary Name: VENLAFAXINE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: EQ 150MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A200834
Product Number: 003
Approval Date: Apr 14, 2011
Applicant Holder Full Name: AUROBINDO PHARMA LIMITED
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: VENLAFAXINE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: EQ 150MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A200834
Product Number: 003
Approval Date: Apr 14, 2011
Applicant Holder Full Name: AUROBINDO PHARMA LIMITED
Marketing Status: Prescription
Patent and Exclusivity Information